![]() | Sensitisation of glioblastoma cells to X-rays and proton in-vitro irradiation with Olaparib, a poly(ADP-ribose) polymerase inhibitor Anne-Catherine Wéra, Alexis Dimitriadis, Miriam Barry, Jonathan C. Jeynes, Michael J.DocID: 1mPF4 - View Document |
![]() | Final results of the phase I first-in-man trial of niraparib (MK4827), a poly(ADP)ribose polymerase (PARP) inhibitor incorporating proof of concept biomarker studies and expansion cohorts involving BRCA1/2 mutation carriDocID: 1lhcT - View Document |
![]() | Microsoft Word - BeiGene BGB 290 FPI Release_FinalDocID: 1anIY - View Document |
![]() | Microsoft Word - ResveratrolDocID: 19OOd - View Document |
![]() | Session.5.Discussion.Blanke.Handouts.1.SRB.pptxpptx (Read-Only)DocID: 19qmw - View Document |